Table 5 Genotype distribution in COVID-19 patients and healthy controls disaggregated by sex
SNP | Sex | Subjects (n) | Genotype frequencies (%) | P | OR; 95% CI | ||
|---|---|---|---|---|---|---|---|
AA | GA | GG | |||||
G8790A | Female | Non-COVID-19 (n = 24) | 4 (17.7) | 9 (37.5) | 11 (45.8) | 0.005 | 5.2; 1.7–16.5 |
COVID-19 (n = 38) | 2 (5.3) | 5 (13.1) | 31 (81.6) |  |  | ||
Male | Non-COVID-19 (n = 26) | 3 (11.5) | 10 (38.5) | 13 (50) | 0.002 | 5.8; 1.8–18.6 | |
COVID-19 (n = 41) | 0 (0) | 6 (14.6) | 35 (85.4) |  |  | ||
A2350G | Female | Non-COVID-19 (n = 24) | 12 (50) | 9 (37.5) | 3 (12.5) | 0.01 | 5.6; 1.4–22.3 |
COVID-19 (n = 38) | 8 (21) | 13 (34.2) | 17 (44.7) |  |  | ||
Male | Non-COVID-19 (n = 26) | 10 (38.5) | 11 (42.3) | 5 (19.2) | 0.9 | 1.2; 0.35–4.0 | |
COVID-19 (n = 41) | 12 (29.2) | 20 (48.8) | 9 (22) |  |  | ||